Offering Cost-Effective Solutions to Biosimilar Development
Biosimilar medicines are revolutionizing patient care, providing an affordable alternative to traditional biologics. However, drug developers face a significant challenge in controlling production costs while achieving the high standards of efficacy and similarity required of biosimilars.
Purolite AP+80 is engineered to support large-scale purification processes necessary for the manufacturing of biosimilar medicines.
With an 80-micron bead, Purolite AP+80 offers ideal flow conditions to maximize production speed.
Purolite AP+80 offers comparable performance and improved process economics compared to market- leading resins.
Purolite™ Chromatography Resins
Purolite AP+80 is manufactured using patented Jetting technology, ensuring uniform particle size for enhanced quality and performance.
Jetting manufacturing supports sustainability through reduced use of harmful solvents and water usage. Compared to traditional methods, Jetting accelerates time to market with fewer production steps.